logo
Plus   Neg
Share
Email

Simcere Names Hongquan Liu CEO, Executive Director - Quick Facts

Simcere Pharmaceutical Group (SCR) said it appointed Hongquan Liu as its chief executive officer, or CEO, and executive director of the Board, effective October 8, 2012. Jinsheng Ren will continue to serve as chairman of Simcere.

Between 2000 and 2012, Liu held the positions of director and general manager of Sino-Swed Pharmaceutical Corp. Ltd. Before that, he held the positions of chief financial officer and chief marketing and business officer of Pharmacia & Upjohn (China) Ltd., and general manager of Pharmacia Corp.

In addition, Simcere announced that Dr. Yehong Zhang, who currently serves as its president, will serve as CEO of Simcere MSD (Shanghai) Pharmaceutical Co. Ltd, the newly established joint venture between Simcere and Merck & Co., Inc. (MRK), effective from October 8, 2012. Dr. Zhang will no longer hold the position of president of Simcere.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Amazon.com Inc. (AMZN) Thursday reported a first-quarter profit that more than doubled from a year ago, driven largely by a huge 46 percent growth in revenues. Shares of the online retailer gained 6 percent in extended session. Seattle, Washington-based Amazon reported first-quarter profit of $1.63... Software giant Microsoft Corp. (MSFT), Thursday reported an increase in profit for the third-quarter that trumped analysts' estimates, driven largely by strong growth in cloud business, as the software giant continues its transition from key software business to cloud business. Redmond, Washington-based... Shares of Deutsche Bank were losing around 2 percent in German trading after the banking giant reported lower profit and revenues in its first quarter with weakness in all segments, mainly Corporate & Investment Bank. Separately, the bank announced actions to reshape its Corporate & Investment Bank and additional cost-cutting measures, including job cuts.
Follow RTT